Targeting the Spleen as an Alternative Site for Hematopoiesis

Research output: Contribution to journalArticleResearchpeer-review

130 Downloads (Pure)

Abstract

Bone marrow is the main site for hematopoiesis in adults. It acts as a niche for hematopoietic stem cells (HSC) and contains non-hematopoietic cells that contribute to stem cell dormancy, quiescence, self-renewal and differentiation. HSC also exist in resting spleen of several species, although their contribution to hematopoiesis under steady-state conditions is unknown. Spleen can however can undergo extramedullary hematopoiesis (EMH) triggered by physiological stress or disease. With loss of bone marrow niches on aging and disease, spleen as an alternative tissue site for hematopoiesis is an important consideration for future therapy particularly during HSC transplantation.

In terms of harnessing spleen as a site for hematopoiesis, here we consider the remarkable regenerative capacity of spleen with a view to forming additional or ectopic spleen tissue through cell engraftment. Studies in mice indicate potential for such grafts to support the influx of hematopoietic cells leading to development of normal spleen architecture. An important goal will be the formation of functional ectopic spleen tissue as an aid to hematopoietic recovery following clinical treatments that impact bone marrow. For example, expansion or replacement of niches could be considered where myeloablation ahead of HSC transplantation compromises treatment outcomes.
Original languageEnglish
Article number1800234
Pages (from-to)1-9
Number of pages9
JournalBioEssays
Volume41
Issue number5
Early online date10 Apr 2019
DOIs
Publication statusPublished - May 2019

Fingerprint

Hematopoiesis
Stem cells
Spleen
Bone
Tissue
Choristoma
Bone Marrow
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells
Grafts
Extramedullary Hematopoiesis
Aging of materials
Physiological Stress
Recovery
Stem Cells
Transplants
Therapeutics

Cite this

@article{b267d1eab02a43c2809b84d92a9b8238,
title = "Targeting the Spleen as an Alternative Site for Hematopoiesis",
abstract = "Bone marrow is the main site for hematopoiesis in adults. It acts as a niche for hematopoietic stem cells (HSC) and contains non-hematopoietic cells that contribute to stem cell dormancy, quiescence, self-renewal and differentiation. HSC also exist in resting spleen of several species, although their contribution to hematopoiesis under steady-state conditions is unknown. Spleen can however can undergo extramedullary hematopoiesis (EMH) triggered by physiological stress or disease. With loss of bone marrow niches on aging and disease, spleen as an alternative tissue site for hematopoiesis is an important consideration for future therapy particularly during HSC transplantation.In terms of harnessing spleen as a site for hematopoiesis, here we consider the remarkable regenerative capacity of spleen with a view to forming additional or ectopic spleen tissue through cell engraftment. Studies in mice indicate potential for such grafts to support the influx of hematopoietic cells leading to development of normal spleen architecture. An important goal will be the formation of functional ectopic spleen tissue as an aid to hematopoietic recovery following clinical treatments that impact bone marrow. For example, expansion or replacement of niches could be considered where myeloablation ahead of HSC transplantation compromises treatment outcomes.",
author = "Christie Short and Hong Lim and Tan, {Jonathan Kah Huat} and O'Neill, {Helen C}",
note = "{\circledC} 2019 WILEY Periodicals, Inc.",
year = "2019",
month = "5",
doi = "10.1002/bies.201800234",
language = "English",
volume = "41",
pages = "1--9",
journal = "BioEssays",
issn = "0265-9247",
publisher = "John Wiley & Sons",
number = "5",

}

Targeting the Spleen as an Alternative Site for Hematopoiesis. / Short, Christie; Lim, Hong; Tan, Jonathan Kah Huat; O'Neill, Helen C.

In: BioEssays, Vol. 41, No. 5, 1800234, 05.2019, p. 1-9.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Targeting the Spleen as an Alternative Site for Hematopoiesis

AU - Short, Christie

AU - Lim, Hong

AU - Tan, Jonathan Kah Huat

AU - O'Neill, Helen C

N1 - © 2019 WILEY Periodicals, Inc.

PY - 2019/5

Y1 - 2019/5

N2 - Bone marrow is the main site for hematopoiesis in adults. It acts as a niche for hematopoietic stem cells (HSC) and contains non-hematopoietic cells that contribute to stem cell dormancy, quiescence, self-renewal and differentiation. HSC also exist in resting spleen of several species, although their contribution to hematopoiesis under steady-state conditions is unknown. Spleen can however can undergo extramedullary hematopoiesis (EMH) triggered by physiological stress or disease. With loss of bone marrow niches on aging and disease, spleen as an alternative tissue site for hematopoiesis is an important consideration for future therapy particularly during HSC transplantation.In terms of harnessing spleen as a site for hematopoiesis, here we consider the remarkable regenerative capacity of spleen with a view to forming additional or ectopic spleen tissue through cell engraftment. Studies in mice indicate potential for such grafts to support the influx of hematopoietic cells leading to development of normal spleen architecture. An important goal will be the formation of functional ectopic spleen tissue as an aid to hematopoietic recovery following clinical treatments that impact bone marrow. For example, expansion or replacement of niches could be considered where myeloablation ahead of HSC transplantation compromises treatment outcomes.

AB - Bone marrow is the main site for hematopoiesis in adults. It acts as a niche for hematopoietic stem cells (HSC) and contains non-hematopoietic cells that contribute to stem cell dormancy, quiescence, self-renewal and differentiation. HSC also exist in resting spleen of several species, although their contribution to hematopoiesis under steady-state conditions is unknown. Spleen can however can undergo extramedullary hematopoiesis (EMH) triggered by physiological stress or disease. With loss of bone marrow niches on aging and disease, spleen as an alternative tissue site for hematopoiesis is an important consideration for future therapy particularly during HSC transplantation.In terms of harnessing spleen as a site for hematopoiesis, here we consider the remarkable regenerative capacity of spleen with a view to forming additional or ectopic spleen tissue through cell engraftment. Studies in mice indicate potential for such grafts to support the influx of hematopoietic cells leading to development of normal spleen architecture. An important goal will be the formation of functional ectopic spleen tissue as an aid to hematopoietic recovery following clinical treatments that impact bone marrow. For example, expansion or replacement of niches could be considered where myeloablation ahead of HSC transplantation compromises treatment outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85064907924&partnerID=8YFLogxK

U2 - 10.1002/bies.201800234

DO - 10.1002/bies.201800234

M3 - Article

VL - 41

SP - 1

EP - 9

JO - BioEssays

JF - BioEssays

SN - 0265-9247

IS - 5

M1 - 1800234

ER -